Catalyst Event
Amgen Inc (AMGN) · Other
From KEDI U.S. Tech100 90% Participation + Daily Options Premium Index (KUSTC100P)
6/7/2026, 12:00:00 AM
Presented new Phase 3 subgroup data for Repatha at the American Diabetes Association (ADA) 86th Scientific Sessions, showing a 29% reduction in cardiovascular risk; medium impact estimated due to clinical significance, expected.
Korean Translation
미국 당뇨병 협회(ADA) 제86차 과학 세션에서 레파타에 대한 새로운 3상 하위 그룹 데이터를 발표했으며, 고위험 당뇨병 환자의 심혈관 위험 감소를 입증함; 임상 데이터의 중요성에 따른 중간 수준의 영향이 예상됨.
Related Recent Events
Baidu Inc (BIDU) · Earnings Release
Baidu's Q2 2026 earnings release is expected around August 26, 2026. Low importance estimated as pre-release anticipation usually results in minor price fluctuations of 1-5%, expected.
8/26/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Other
A quarterly dividend of $0.53 per share is expected, with an ex-dividend date of August 20, 2026. Low importance is assigned as standard dividend events typically result in a <5% price impact, expected.
8/20/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Earnings Release
The Q3 2026 earnings release is scheduled for August 13, 2026. Low importance is assigned as the announcement of a reporting date typically has a <5% price impact, scheduled.
8/13/2026, 12:00:00 AM
Cisco Systems Inc (CSCO) · Earnings Release
Cisco is scheduled to release its Q4 and full fiscal year 2026 earnings on August 12, 2026, scheduled. Market reaction estimated at ≥5% based on historical earnings volatility.
8/12/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q2 2026 earnings release scheduled. The company guided for revenue of approximately $11.2 billion, and analysts forecast EPS around $1.55-$1.60. High importance is estimated due to expected >10% volatility scheduled.
8/4/2026, 12:00:00 AM
Teradyne Inc (TER) · Earnings Release
The next quarterly earnings release on August 4, 2026, which is estimated to have a medium impact (≥5%) as a key financial disclosure event, is scheduled.
8/4/2026, 12:00:00 AM